Jan van der Meulen is Professor of Clinical Epidemiology, Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine. He studied medicine and completed a PhD in medical physics in 1989. He has worked as a clinical epidemiologist first in the Netherlands and since 1998 in the UK (MRC Unit Southampton 1998 – 2000; LSHTM 2000 – present).
He was Director of the Clinical Effectiveness Unit, the academic collaboration between the LSHTM and the Royal College of Surgeons of England, between 2001 and 2011 and Honorary Director of the Office for Research and Clinical Audit, Royal College of Obstetricians and Gynaecologists between 2006 and 2014. He was Head of the Department of Health Services Research & Policy, LSHTM, between 2011 and 2014. He chaired the NIHR Research for Patient Benefit Funding Committee for the London Region between 2011 and 2014.
He is a member of the Project Teams of the National Prostate Cancer Audit, the National Kidney Cancer Audit, the National Ovarian Cancer Audit and the National Maternity and Perinatal Audit. He is also a member of the executive team of the National Cancer Audit Collaborating Centre.
His main fields of interest are the application of epidemiological, statistical, and decision-analytical techniques to study effectiveness and quality of care in the areas of surgery, cancer, obstetrics and gynaecology, using electronic health records.
Affiliations
Teaching
I am involved in the Public Health MSc. I am a co-organiser of the Proposal Development MSc module.
Research
The central theme of my research is the study of determinants of variation in processes and outcomes of care ("epidemiology of the quality of care"). I am involved in a number of national studies of clinical practice and outcome that are run by the Clinical Effectiveness Unit of the Royal College of Surgeons of England. I do similar work within obstetrics and gynaecology in collaboration with the Royal College of Obstetricians and Gynaecologists.
Other topics of my research include methods for case-mix adjustment, continuous monitoring of outcomes, and the usefulness of routine databases for research and healthcare performance assessment.
Previous work looked at the effect of the fetal environment on the development of disease later in life.